| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10964219 | Vaccine | 2015 | 8 Pages |
Abstract
Our study suggests that the introduction of two-dose hepatitis A vaccines in Panama has contributed to the reduction in the incidence of overall hepatitis-related outcomes for all age groups, suggesting herd protection. Additional monitoring is required to document a sustained long-term effect.
Keywords
Strategic Advisory Group of ExpertsHEPHDNHAVNBRSASALTUniversal mass vaccinationIgMHEPAUMVASTAspartate aminotransferaseAlanine aminotransferasemicroparticle enzyme immunoassayimmunoglobulin MMEIASAGEICDNegative binomial regressionWorld Health OrganisationStatistical Analysis SystemInternational Classification of Diseasesconfidence intervalHepatitis Ahepatitis A vaccineVaccinationMoHMinistry of Healthhepatitis A virusPanamaWHO
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Dora Estripeaut, Rodolfo Contreras, Olga Tinajeros, Maria Mercedes Castrejón, Fakrudeen Shafi, Eduardo Ortega-Barria, Rodrigo DeAntonio,